SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a sharp selloff across AI neocloud stocks, as traders debate financing costs, debt exposure and whether providers can earn acceptable returns on their infrastructure buildouts. Bulls see the decline as an oversold sector pullback and cite insider buying and persistent AI-compute demand, while bears warn that the business model and broader AI trade remain risky.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The prolonged wait for the 80th death event in SELLASs blinded Phase 3 REGAL AML triallast reported at 78 of 80has traders speculating that survival is extended and results could be presented around ASH. Others caution that the delay and CEOs anniversary post do not establish trial success or an imminent deal, amid a sharp share decline; SLS009 data is another, secondary focus.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is under heavy selling pressure alongside AI data-center and neocloud stocks, as traders focus on CoreWeaves credit concerns, higher borrowing costs, and uncertainty about financing APLDs expansion. The debate contrasts concerns over debt, dilution, and execution with bullish views pointing to insider buying, contracted leases, and delivered capacity.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade of CoreWeave to Buy is fueling a rebound debate after a steep selloff tied to concerns about the companys debt burden, borrowing costs, and financing needs. Bullish traders view the upgrade and AI demand as support for recovery, while skeptics argue that credit-market stress and heavy leverage remain serious risks.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is drawing attention after stronger-than-guided Q3 results and a more upbeat 2027 adjusted EBITDA outlook. Bulls cite improving operations and possible short covering, while skeptics question whether earnings gains can overcome the companys substantial debt.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULF is drawing attention amid a sharp selloff in AI-infrastructure stocks and a Morgan Stanley report arguing its decline is out of line with its contracts and potential catalysts. Traders disagree on whether financing, debt and sector concerns outweigh the companys power-and-data-center model, with some viewing the heavy-volume rebound and CEO defense of that model as signs of a possible recovery.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

EyePoints decision to cut its workforce and end its pivotal wet-AMD trials is driving attention, with traders debating whether it removes a competitor for Ocular or instead deepens skepticism about retinal drug development and weighs on the sector. Discussion also centers on the pending AXPAXLI NDA, but speculation about a competitive benefit has not prevented bearish reactions to OCULs share-price weakness.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Renewed takeover speculation is driving attention, with traders discussing an unconfirmed report that an unnamed West Coast tech company may be evaluating an all-stock deal; many guess Meta, but no offer or buyer has been confirmed. The community is split between expecting a premium bid and viewing the rumor as a short-lived pump, while some focus on PayPals standalone turnaround and upcoming earnings.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

The FDA accepted CorMedixs supplemental REZZAYO application for priority review to expand use into preventing invasive fungal disease in transplant patients, with a target decision date in Q1 2027. Traders see the faster review and potential new indication as a growth catalyst, while noting that filing acceptance does not guarantee approval.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Investors are focused on the expected completion of Compass Pathways rolling NDA for COMP360, its investigational treatment for treatment-resistant depression, and the prospect of an accelerated FDA review. The selloff has prompted concern that the filing may take longer, amplified by the CEOs cautious comments and biotech-sector weakness, while bullish traders view the pullback as volatility ahead of a key regulatory milestone.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nanobiotix (NASDAQ:NBTX) Trading 12.5% Higher   - Should You Buy?

Nanobiotix (NASDAQ:NBTX) Stock Price Up 12.5% - Still a Buy...

Nanobiotix (NASDAQ:NBTX) Shares Gap Up   - Still a Buy?

Nanobiotix (NASDAQ:NBTX) Shares Gap Up - Here's What Happened...

Nanobiotix (NASDAQ:NBTX) Shares Gap Down - What's Next?

Nanobiotix (NASDAQ:NBTX) Shares Gap Down - Time to Sell...

Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading Volume  - Here's What Happened

Nanobiotix (NASDAQ:NBTX) Sees Strong Trading Volume - What's Next...

Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX) Sees Significant Decline in Short Interest

Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX - Get Free Report) was the target of a large decrease in short interest in the month of April. As of April 15th, there was short interest totaling 11,234...

Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX) Given Average Rating of "Moderate Buy" by Analysts

Shares of Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five analysts that are currently covering the company...

Nanobiotix (NASDAQ:NBTX) Trading 7.2% Higher - Should You Buy?

Nanobiotix (NASDAQ:NBTX) Trading 7.2% Higher - Should You Buy...

Nanobiotix (NASDAQ:NBTX) Shares Gap Down   - Here's What Happened

Nanobiotix (NASDAQ:NBTX) Shares Down 6.6% - Here's What Happened

Nanobiotix (NASDAQ:NBTX) Stock Price Down 6.6% - Here's Why...

FY2026 EPS Estimates for Nanobiotix Lifted by HC Wainwright

Nanobiotix S.A. - Sponsored ADR (NASDAQ:NBTX - Free Report) - Equities researchers at HC Wainwright lifted their FY2026 EPS estimates for shares of Nanobiotix in a research note issued on Monday...

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.

Nanobiotix - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$21.30
Prev Close	$22.23
Open	$22.19
Dividend Yield	0.00%
50-Day Moving Average	$34.66
Beta	1.07
Avg. Volume	134,563.35
PE Ratio	-16.82

52-Week High	$57.14
52-Week Low	$14.78
Market Capitalization	$1.08B
EPS (Annual)	-$0.5655
Price to Book	-28.35
Revenue Per Employee	$344,891.09

Feed

News

Sentiment

Earnings

Fundamentals

Info

NBTX Fundamentals